Simple SummaryThere are no effective treatments for patients with cancers that induce airway narrowing via extrinsic pressure to the bronchus (i.e., extrinsic malignant central airway obstruction—MCAO). The effects of these cancerous tumors must be quickly alleviated to allow normal breathing and delay disease progression. Currently, stents are used to keep the airway open, but stents do not halt the progression of the cancerous tumor that can crush the stent. We have shown that interstitial photodynamic therapy (I-PDT) can be a safe and beneficial treatment option for patients with extrinsic MCAO. Image-based pre-treatment planning is critical for patient safety and tumor response in I-PDT. Herein, we present and validate novel image-based computer optimization methods for guiding light administration in I-PDT of extrinsic MCAO, based on a rate-based light dose metric. We demonstrate the benefit of our approach in data from representative patients with extrinsic MCAO who were treated with I-PDT.AbstractThere are no effective treatments for patients with extrinsic malignant central airway obstruction (MCAO). In a recent clinical study, we demonstrated that interstitial photodynamic therapy (I-PDT) is a safe and potentially effective treatment for patients with extrinsic MCAO. In previous preclinical studies, we reported that a minimum light irradiance and fluence should be maintained within a significant volume of the target tumor to obtain an effective PDT response. In this paper, we present a computational approach to personalized treatment planning of light delivery in I-PDT that simultaneously optimizes the delivered irradiance and fluence using finite element method (FEM) solvers of either Comsol Multiphysics®or Dosie™ for light propagation. The FEM simulations were validated with light dosimetry measurements in a solid phantom with tissue-like optical properties. The agreement between the treatment plans generated by two FEMs was tested using typical imaging data from four patients with extrinsic MCAO treated with I-PDT. The concordance correlation coefficient (CCC) and its 95% confidence interval (95% CI) were used to test the agreement between the simulation results and measurements, and between the two FEMs treatment plans. Dosie with CCC = 0.994 (95% CI, 0.953–0.996) and Comsol with CCC = 0.999 (95% CI, 0.985–0.999) showed excellent agreement with light measurements in the phantom. The CCC analysis showed very good agreement between Comsol and Dosie treatment plans for irradiance (95% CI, CCC: 0.996–0.999) and fluence (95% CI, CCC: 0.916–0.987) in using patients’ data. In previous preclinical work, we demonstrated that effective I-PDT is associated with a computed light dose of ≥45 J/cm2when the irradiance is ≥8.6 mW/cm2(i.e., the effective rate-based light dose). In this paper, we show how to use Comsol and Dosie packages to optimize rate-based light dose, and we present Dosie’s newly developed domination sub-maps method to improve the planning of the delivery of the effective rate-based light dose. We conclude that image-based treatment planning using Comsol or Dosie FEM-solvers is a valid approach to guide the light dosimetry in I-PDT of patients with MCAO.